Veralto Posts Fourth EPS Beat, Both Segment Chiefs Sell
Veralto Corporation achieved its fourth consecutive quarterly earnings beat in Q3 2026, reporting $1.18 in adjusted EPS and 7.9% revenue growth to $1.51 billion. Yet all five executives who filed Form
Veralto Posts Fourth EPS Beat, Both Segment Chiefs Sell
NEW YORK, November 15 —
Veralto Corporation (VLTO) beat Zacks consensus for the fourth consecutive quarter on October 29, with Q3 2026 EPS of $1.18 topping expectations by 7.27% and revenue rising 7.9% to $1.51 billion. In the three weeks surrounding the report, every executive who filed a Form 4 sold their entire option-exercise position, retaining nothing.
- Q3 2026 adjusted EPS of $1.18 beat Zacks consensus by 7.27%; year-ago quarter was $0.99 per share.
- Both segment SVPs liquidated full option-exercise positions post-earnings; $6.64 million in insider sales against zero purchases in 90 days.
- Consensus target of $124.63 implies 5.4% upside; shares up 3% year-to-date vs. S&P 500's 13.1%.
Why Four Beats Made Sense
Veralto's Water Quality segment, built around Hach instruments, Trojan UV disinfection systems, and ChemTreat chemicals, serves utilities and industrial customers where service contracts drive recurring revenue. The PQI segment sells Videojet and Linx coding systems to packaged goods manufacturers alongside Esko design software and Pantone color standards. The business carries a 59.8% gross margin and $763 million in trailing free cash flow on $5.80 billion in revenue, a capital-light profile unusual in industrials. That recurring structure explains the consistency: EPS beat consensus by +6.1%, +6.0%, +9.9%, and +8.3% in the last four quarters, all per the October 29 8-K.
Five Sellers, Zero Buyers
Five executives filed Form 4s over the 90-day window ending November 10, generating $6.64 million in sales against zero purchases. Every transaction followed the same script: exercise options, sell the entire position the same day, keep nothing. CEO Jennifer Honeycutt sold 7,098 shares at $105.00 six days before the report; SVP Strategy Surekha Trivedi sold 36,427 shares the day after for $3.97 million. SVP PQI Mattias Bystrom sold 9,069 shares across eight transactions on November 3; SVP Water Quality Melissa Kapity sold 5,146 shares on November 10. With insider ownership at 0.9%, the people who run these businesses are not buying at any price in the rally.
| Ticker | Mkt cap | Fwd P/E | 52-wk |
|---|---|---|---|
| VLTO | $28.8B | 24.2x | +20.6% |
| RVTY | $17.2B | 25.9x | +69.5% |
| FTV | $20.2B | 20.4x | +34.4% |
| EG | $15.8B | 7.0x | +33.4% |
| CPAY | $29.6B | 14.5x | +68.6% |
| BALL | $17.0B | 14.6x | +37.8% |
What the Multiple Already Knows
The sell-the-day-of discipline is not unusual on its own; executives routinely liquidate options near expiry. What narrows the charitable read is the breadth: five Form 4s in a 19-day window spanning the report, the stock moving from $105 on October 23 to $118 by November 10, no seller retaining a share. At 24.4x forward earnings, the consensus target of $124.63 implies just 5.4% upside; the DCF calculator shows how quickly a growth slowdown erases it. Revenue growth is the Q4 watchpoint: if the 7.9% rate softens, a multiple priced for continued execution leaves little margin for error. Run the free Veralto Corporation deep-dive →
Basis Report is independent research for informational purposes. It is not investment advice and not a recommendation to buy or sell any security.
Frequently Asked Questions
Did Veralto beat earnings estimates?
Yes, Veralto beat Zacks consensus for the fourth consecutive quarter on October 29. Q3 2026 adjusted EPS was $1.18, topping expectations by 7.27%, with revenue rising 7.9% to $1.51 billion year-over-year. The four consecutive beats included margin increases of 6.1%, 6.0%, 9.9%, and 8.3% versus consensus.
How much did Veralto insiders sell?
Five executives sold a combined $6.64 million in stock over the 90-day window ending November 10, with zero purchases. Every executive who filed a Form 4 exercised options and immediately sold the entire position the same day, including CEO Jennifer Honeycutt and both segment chiefs: SVP PQI Mattias Bystrom and SVP Water Quality Melissa Kapity.
What does Veralto's business do?
Veralto operates two main segments. The Water Quality segment is built around Hach instruments, Trojan UV disinfection systems, and ChemTreat chemicals, serving utilities and industrial customers. The PQI segment sells Videojet and Linx coding systems to packaged goods manufacturers, plus Esko design software and Pantone color standards.
How much upside does VLTO stock have?
The consensus price target of $124.63 implies 5.4% upside at the stock price of $118 reported in the article. At a 24.4x forward earnings multiple, the stock leaves limited margin for error if revenue growth slows from the recent 7.9% rate.
Why is Veralto beating earnings consistently?
Veralto's recurring revenue structure explains the consistency. The company carries a 59.8% gross margin and $763 million in trailing free cash flow on $5.80 billion in revenue. This capital-light profile is unusual in industrials and produces a predictable earnings stream.
Veralto Corporation posted its fourth consecutive quarterly earnings beat on October 29, with Q3 2026 EPS of $1.18 topping consensus by 7.27% and revenue rising 7.9% year-over-year to $1.51 billion. Within two weeks of the report, every executive who filed a Form 4 — including both segment heads — had sold their entire option-exercise position into the rally, with zero open-market purchases recorded across the full 90-day window.